Nalaganje...
Profile of Xeomin(®) (incobotulinumtoxinA) for the treatment of blepharospasm
Even though conventional botulinum neurotoxin (BoNT) products have shown successful treatment results in patients with benign blepharospasm (BEB), the main, potential long-term side effect of BoNT use is the development of immunologic resistance due to the production of neutralizing antibody to the...
Shranjeno v:
| Main Authors: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2011
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3116796/ https://ncbi.nlm.nih.gov/pubmed/21691580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OPTH.S13978 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|